eScholarship
metadata only
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
Renal cell carcinoma (RCC) is increasing in incidence, and a complete cure remains elusive. While immune-checkpoint antibodies are promising, interferon-based immunotherapy has been disappointing. Tryptophan metabolism, which produces immunosuppressive metabolites, is enhanced in RCC. Here we show i
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer#862083
- The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma#268874
- Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells#460083
- Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer#807820
- Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer#287524
Record · ID 1165989
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive